-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Netivudine
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/84558-93-0.gif)
| Category | Herpes simplex Virus (HSV) |
| CAS | 84558-93-0 |
| Description | Netivudine, a nucleoside analogue, has potent anti-varicella zoster virus activity. |
Product Information
| Synonyms | 882C87; 5-propynylarabinofuranosyluracil; 2,4(1H,3H)-Pyrimidinedione, 1-β-D-arabinofuranosyl-5-(1-propyn-1-yl)-; 1-(beta-D-Arabinofuranosyl)-5-(1-propynyl)uracil; 1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-prop-1-ynyl-pyrimidine-2,4-dione; 1-(β-D-Arabinofuranosyl)-5-(prop-1-yn-1-yl)dihydropyrimidine-2,4(1H,3H)-dione |
| IUPAC Name | 1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-prop-1-ynylpyrimidine-2,4-dione |
| Molecular Weight | 282.25 |
| Molecular Formula | C12H14N2O6 |
| Canonical SMILES | CC#CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O |
| InChI | InChI=1S/C12H14N2O6/c1-2-3-6-4-14(12(19)13-10(6)18)11-9(17)8(16)7(5-15)20-11/h4,7-9,11,15-17H,5H2,1H3,(H,13,18,19)/t7-,8-,9+,11-/m1/s1 |
| InChIKey | QLOCVMVCRJOTTM-SDNRWEOFSA-N |
| Purity | 95% |
| Density | 1.61±0.1 g/cm3 (Predicted) |
| Solubility | Soluble in DMSO |
| Appearance | Solid Powder |
| Application | Antiviral Agents |
| Storage | Store at 2-8°C for short term (days to weeks) or -20°C for long term (months to years) |
| Complexity | 531 |
| Exact Mass | 282.08518617 |
| Index Of Refraction | 1.636 |
| PSA | 124.78000 |
| Target | Nucleoside Antimetabolite/Analog; HSV |
| XLogP3-AA | -1.2 |
